Trial intelligence / Profile preview

Influence of stress on Parkinson's tremor

ISRCTN89589002Phase 2Completed

Sponsor
Radboud University
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of propranolol in Parkinson's disease (PD) (2 cohorts), sponsored by Radboud University. Primary endpoints: Tremor-related brain activity and connectivity and Tremor intensity. Started Sep 2019; status: completed.

02

Drugs

propranolol
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on ISRCTN89589002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN89589002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call